Healthcare · Medical - Pharmaceuticals
Price
$0.60
Market Cap
$1.3M
Employees
12
Beta
-0.39
Avg Volume
2,340,848
CEO
Sing Ee Wong
Business Description
Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.
Business History
Price Overview
Last updated: Jun 27, 2026 9:01am (just now)$0.60
0.00 (-0.17%)
Day Range
$0.57 – $0.64
52-Week Range
$0.57 – $19.87
50-Day MA
$0.96
200-Day MA
$1.74
Volume
38,585.00
Share Structure
Outstanding
2,184,210.00
Float
2,148,201.00
Free Float
98.4%
High free float
— 98.4% of shares trade freely, ~1.6% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Small absolute float (2.1M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.09
Stock Price: $0.60
EPS (Diluted): -6.45
EPS (Diluted): -6.45
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.47
Stock Price: $0.60
Total Equity: $6.84M
Shares: 2,185,075
Total Equity: $6.84M
Shares: 2,185,075
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
0.56
Market Cap: $1.31M
Total Debt: $0.00
Cash: $3.51M
EBITDA: -$8.42M
Total Debt: $0.00
Cash: $3.51M
EBITDA: -$8.42M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$-269,089
Market Cap: $1.31M
Total Debt: $0.00
Cash: $3.51M
Total Debt: $0.00
Cash: $3.51M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
4.33
Stock Price: $0.60
Revenue: $747,000
Shares: 2,185,075
Revenue: $747,000
Shares: 2,185,075
EV/Sales (Total value vs revenue — works when P/E can't)
API-0.36
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
18.5%
Gross Profit: $138,000
Revenue: $747,000
Revenue: $747,000
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-1,128.1%
Operating Income: -$8.43M
Revenue: $747,000
Revenue: $747,000
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-401.3%
Net Income: -$3.00M
Revenue: $747,000
Revenue: $747,000
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-51.2%
Net Income: -$3.00M
Total Equity: $6.84M
Total Equity: $6.84M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-53.7%
Operating Income: -$8.43M
Tax Rate: -0.2%
Equity: $6.84M
Total Debt: $0.00
Cash: $3.51M
Tax Rate: -0.2%
Equity: $6.84M
Total Debt: $0.00
Cash: $3.51M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
4.70
Current Assets: $6.26M
Current Liabilities: $1.33M
Current Liabilities: $1.33M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $6.84M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $6.84M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.34
Revenue: $747,000
Shares: 2,185,075
Shares: 2,185,075
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$3.13
Total Equity: $6.84M
Shares: 2,185,075
Shares: 2,185,075
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-2.18
Operating CF: -$4.77M
CapEx: $0.00
Shares: 2,185,075
CapEx: $0.00
Shares: 2,185,075
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
1.9%
Last Dividend: N/A
Stock Price: $0.60
Stock Price: $0.60
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$3.00M
Net Income: -$3.00M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares BGMS against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 23, 2026 12:19pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $420,000 | $43,000 | $747,000 |
| Cost of Revenue | $43,000 | $32,000 | $31,000 | $6,000 | $609,000 |
| Gross Profit | $-43,000 | $-32,000 | $420,000 | $43,000 | $138,000 |
| Operating Expenses | $22.4M | $27.7M | $25.9M | $12.0M | $8.6M |
| Operating Income | -$22.4M | -$27.7M | -$25.5M | -$12.0M | -$8.4M |
| Net Income | -$18.5M | -$21.2M | -$22.6M | -$11.2M | -$3.0M |
| EBITDA | -$22.3M | -$27.6M | -$25.4M | -$12.0M | -$8.4M |
| EPS | $-7,704.00 | $-6,840.00 | $-6,420.00 | $-501.60 | $-6.45 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 12:19pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $36.6M | $18.3M | $3.4M | $3.1M | $3.5M |
| Total Current Assets | $40.9M | $24.4M | $7.4M | $3.7M | $6.3M |
| Total Assets | $43.1M | $28.1M | $8.8M | $4.1M | $8.2M |
| Current Liabilities | $5.4M | $7.5M | $8.2M | $6.3M | $1.3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $5.4M | $7.6M | $8.2M | $6.3M | $1.3M |
| Total Equity | $37.7M | $20.4M | $607,000 | -$2.2M | $6.8M |
| Retained Earnings | -$384.5M | -$405.7M | -$428.3M | -$439.5M | -$454.4M |
Cash Flow (Annual)
Last updated: Jun 23, 2026 12:19pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$18.5M | -$20.8M | -$16.1M | -$8.0M | -$4.8M |
| Capital Expenditure | $-27,000 | $-7,000 | $-6,000 | $0 | $0 |
| Free Cash Flow | -$18.6M | -$20.8M | -$16.1M | -$8.0M | -$4.8M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $3.2M | -$18.2M | -$15.0M | $-241,000 | $368,000 |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 9:01am (just now)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$100,000 $100,000 – $100,000
|
$100,000 $100,000 – $100,000
|
$80.6M $80.6M – $80.6M
|
$118.1M $118.1M – $118.1M
|
| EBITDA |
$-19,999 $-19,999 – $-19,999
|
$-19,999 $-19,999 – $-19,999
|
-$16.1M -$16.1M – -$16.1M
|
-$23.6M -$23.6M – -$23.6M
|
| Net Income |
-$618.8M -$618.8M – -$618.8M
|
-$587.3M -$587.3M – -$587.3M
|
$1.9B $1.9B – $1.9B
|
$2.9B $2.9B – $2.9B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 12:19pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | -89.8% | +1,637.2% |
| Gross Profit Growth | +25.6% | +1,412.5% | -89.8% | +220.9% |
| Operating Income Growth | -23.5% | +8.0% | +52.8% | +29.8% |
| Net Income Growth | -14.9% | -6.4% | +50.3% | +73.3% |
| EBITDA Growth | -23.6% | +8.0% | +52.8% | +29.8% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2025-11-12 | Kiu Cu Seng | A-Award | 200,000.00 | $1.40 | $280,000 |
| 2025-11-12 | Doris Wong Sing Ee | A-Award | 300,178.00 | $1.40 | $420,249 |
| 2025-11-05 | Yap Kim Choy | J-Other | 467,535.00 | $0.00 | $0 |
| 2025-11-05 | Yap Kim Choy | J-Other | 218,000.00 | $7.65 | $1.7M |
| 2025-11-05 | Yap Kim Choy | J-Other | 218,000.00 | $9.00 | $2.0M |
| 2025-11-05 | Yap Kim Choy | J-Other | 31,535.00 | $10.20 | $321,657 |
| 2025-11-05 | Yap Kim Choy | S-Sale | 28,540.00 | $1.70 | $48,518 |
| 2025-11-05 | Ong Yee Lung | J-Other | 467,535.00 | $0.00 | $0 |
| 2025-11-05 | Kua Khai Loon | J-Other | 467,535.00 | $0.00 | $0 |
| 2025-11-05 | Kua Khai Loon | J-Other | 218,000.00 | $9.00 | $2.0M |
| 2025-11-05 | Ong Yee Lung | J-Other | 218,000.00 | $9.00 | $2.0M |
| 2025-11-05 | Ong Yee Lung | J-Other | 31,535.00 | $10.20 | $321,657 |
| 2025-11-05 | Ong Yee Lung | J-Other | 218,000.00 | $7.65 | $1.7M |
| 2025-11-05 | Kua Khai Loon | J-Other | 218,000.00 | $7.65 | $1.7M |
| 2025-11-05 | Kua Khai Loon | J-Other | 31,535.00 | $10.20 | $321,657 |
| 2025-10-30 | Yap Kim Choy | S-Sale | 112,260.00 | $1.81 | $202,854 |
| 2025-10-30 | Kua Khai Loon | S-Sale | 242,477.00 | $1.80 | $436,459 |
| 2025-10-30 | Ong Yee Lung | S-Sale | 248,814.00 | $1.80 | $447,865 |
| 2025-10-29 | Yap Kim Choy | S-Sale | 110,749.00 | $1.83 | $203,114 |
| 2025-10-28 | Yap Kim Choy | S-Sale | 13,111.00 | $1.83 | $23,967 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for BGMS — it's generated by the pipeline (
market-narrative step).
No community reviews yet for BGMS.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30